(Q34743382)

4 August 2017

1 reference

title

Obesity, haemostasis and the fibrinolytic system (English)

1 reference

4 August 2017

0 references

Mertens I

1

1 reference

PubMed ID

12120424

4 August 2017

Van Gaal LF

series ordinal

2

1 reference

4 August 2017

1 May 2002

1 reference

4 August 2017

1 reference

4 August 2017

3

1 reference

4 August 2017

2

1 reference

4 August 2017

85-101

1 reference

Effects of lipids and lipoproteins on thrombosis and rheology.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Haemostatic parameters and vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Body Weight and Mortality among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Interrelations between carbohydrates, lipids, and the hemostatic system in relation to the risk of thrombotic and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrin(ogen) and diabetes mellitus: don't forget fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Hemostatic function in young subjects with central obesity: relationship with left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults--the ARIC study. Atherosclerosis Risk in Communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrinogen in obesity before and after weight reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects--evidence against a modulating role for insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Effect of a short-term very low calorie diet on plasma lipids, fibrinogen, and factor VII in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrinolytic activity and clotting factors in ischaemic heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Haemostatic function in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Insulin sensitivity and haemostatic factors in men at high and low cardiovascular risk. The Risk Factor Intervention Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Mechanisms of physiological fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Prospective study of endogenous tissue plasminogen activator and risk of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Fibrinolysis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-alpha?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass surgery in morbidly obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Hypertriglyceridemia and regulation of fibrinolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

Effect of weight loss on coagulation factors VII and X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1467-789X.2002.00056.X

10.1046/J.1467-789X.2002.00056.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12120424